STOCKHOLM, Sweden--(BUSINESS WIRE)--Orexo (STO:ORXA): This is a complement to the press release from yesterday. In connection with the new agreement with ProStrakan, apart from higher royalty rates, the potential sales milestone payments in Europe have increased from 10.0 MEUR to 19.9 MEUR.
